US Bancorp’s American Renal Associates Holdings, Inc ARA Stock Holding History

US Bancorp’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-202	Closed	-$2K	–	4033
2020 Q4	$2K	Buy	+202	New	+$2.3K	﹤0.01%	3630
2019 Q1	–	Sell	-1,793	Closed	-$21K	–	3697
2018 Q4	$21K	Buy	1,793 +93	+5%	+$1.59K	﹤0.01%	2805
2018 Q3	$37K	Sell	1,700 -6	-0.4%	-$114	﹤0.01%	2710
2018 Q2	$27K	Sell	1,706 -834	-33%	-$13.1K	﹤0.01%	2837
2018 Q1	$48K	Buy	2,540 +1,156	+84%	+$22.8K	﹤0.01%	2646
2017 Q4	$24K	Buy	1,384 +36	+3%	+$497	﹤0.01%	2876
2017 Q3	$21K	Hold	1,348	–	–	﹤0.01%	2890
2017 Q2	$25K	Buy	1,348 +211	+19%	+$3.67K	﹤0.01%	2823
2017 Q1	$19K	Buy	1,137 +32	+3%	+$638	﹤0.01%	2862
2016 Q4	$24K	Buy	+1,105	New	+$22.7K	﹤0.01%	2770

US Bancorp's ARA Position: Q1 2021 in Review

US Bancorp sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 202 shares — an estimated $2K sold.

US Bancorp first reported a position in ARA in Q4 2016 and held it in 10 quarters. The position peaked at $48K in Q1 2018. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.

US Bancorp reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
US Bancorp sold 202 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $2K.
US Bancorp first reported a position in American Renal Associates Holdings, Inc in Q4 2016 and held it in 10 quarters.
US Bancorp's American Renal Associates Holdings, Inc position peaked at $48K in Q1 2018.
0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.

Based on US Bancorp's 13F filing for Q1 2021, filed 28 Apr 2021.